03:17 PM EST, 02/18/2025 (MT Newswires) -- Merck ( MRK ) and a plaintiff suing the company over its human papillomavirus vaccine, Gardasil, have agreed to halt a trial after four weeks of proceedings, Reuters reported Tuesday, citing a company statement.

The plaintiff, Jennifer Robi, alleges that the vaccine caused her impaired mobility.

On Friday, the plaintiff's lawyers proposed discharging the jury and adjourning the case, and Merck ( MRK ) agreed, provided that no financial or other consideration was exchanged, according to the news outlet.

Merck ( MRK ) and Robi plan to reconvene with a new jury in a Los Angeles state court in September, the report added.

Merck ( MRK ) did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 82.84, Change: -0.17, Percent Change: -0.20